Occudo Quantitative Strategies LP Lantheus Holdings, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$60.27 - $90.75 $211,849 - $318,986	3,515 New	3,515 $244,000
Q3 2022 Nov 14, 2022	SELL	$61.42 - $86.29 $1.64 Million - $2.3 Million	-26,666 Reduced 49.81%	26,873 $1.89 Million
Q2 2022 Aug 15, 2022	SELL	$55.54 - $72.65 $3.17 Million - $4.15 Million	-57,122 Reduced 51.62%	53,539 $3.54 Million
Q1 2022 May 16, 2022	BUY	$24.28 - $56.64 $2.28 Million - $5.32 Million	93,930 Added 561.41%	110,661 $6.12 Million
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $22,878 - $30,896	1,015 Added 6.46%	16,731 $483,000
Q3 2021 Nov 15, 2021	BUY	$24.23 - $28.59 $380,798 - $449,320	15,716 New	15,716 $404,000

538

68.4M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.